Intercell tops up $50m funding round
The Austrian vaccine developer has landed the largest biotechnology financing round for two years with lead investments from MPM Capital and Global Life Science Ventures.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- Database
- LP search
- GP search
- Fund search
- Investment Consultant search
- Placement Agent search
- Law Firm search
- Live Fundraising Chart
- Benchmarks
- Institution Profiles Index
- Private Equity Data
- Investor Calendar 2025
- Update your database profile
- Law firm data submission
- Database key terms and methodology
- Fund performance methodology
- Quick Search
- Latest News & Analysis
- Rankings & Reports
- Events
- Bookstore
